2016年6月12日星期日

Lacosamide (racemate)|cas 175481-26-2|DC Chemicals

Lacosamide (racemate)|cas 175481-26-2|DC Chemicals

Lacosamide racemate(Vimpat racemate; Erlosamide  racemate) is a medication developed for the adjunctive treatment of partial-onset seizures and diabetic neuropathic pain.

IC50 value:

Target:

Lacosamide is a functionalized amino acid that produces activity in the maximal electroshock seizure (MES) test, that, like some other antiepileptic drugs (AEDs), are believed to act through voltage-gated sodium channels.

Product Name: Lacosamide (racemate)|Cat No: DC9530|Cas: 175481-26-2|Molecule Formular: C13H18N2O3|Molecule Weight: 250.2936|Other names: Lacosamide (racemate)

Lacosamide racemate(Vimpat racemate; Erlosamide  racemate) is a medication developed for the adjunctive treatment of partial-onset seizures and diabetic neuropathic pain.
Lacosamide is a functionalized amino acid that produces activity in the maximal electroshock seizure (MES) test, that, like some other antiepileptic drugs (AEDs), are believed to act through voltage-gated sodium channels. Lacosamide enhances the slow inactivation of voltage-gated sodium channels without affecting the fast inactivation of voltage-gated sodium channels. This inactivation prevents the channel from opening, helping end the action potential. Many antiepileptic drugs, like carbamazepine or lamotrigine, slow the recovery from inactivation and hence reduce the ability of neurons to fire action potentials.

For research only, not for human use!

没有评论:

发表评论